Respiratory viral infections in immunocompetent and immunocompromised persons

American Journal of Medicine

Volumn 102, Issue 3A, 1997, Pages 2-9

  Couch, Robert B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; RIMANTADINE;

ADENOVIRUS; CANCER PATIENT; CONFERENCE PAPER; CORONAVIRUS; DEATH; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFLUENZA VIRUS; INHALATIONAL DRUG ADMINISTRATION; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; VIRUS INFECTION; VIRUS PNEUMONIA;

BONE MARROW TRANSPLANTATION; CROSS INFECTION; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; INCIDENCE; NEOPLASMS; RESPIRATORY TRACT INFECTIONS; UNITED STATES; VIRUS DISEASES;

EID: 0031007965     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(97)00003-x     Document Type: Article

References (2)

1. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988;127:353-364.
2. Lewis VA, Champlin R, Englund J, et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis. 1996;23:1033-1037.